Blackstone sells Anthos to Novartis for up to $3.1bn
Anthos was founded by Blackstone Life Sciences and Novartis in 2019.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
